Bioinformatics Analysis of Differentially Expressed Genes and Pathways in the Development of Cervical Cancer

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2021 Jun 27

PMID 34174849

Citations 13

Authors

Baojie Wu

Shuyi Xi

Affiliations

Soon will be listed here.

Abstract

Background: This study aimed to explore and identify key genes and signaling pathways that contribute to the progression of cervical cancer to improve prognosis.

Methods: Three gene expression profiles (GSE63514, GSE64217 and GSE138080) were screened and downloaded from the Gene Expression Omnibus database (GEO). Differentially expressed genes (DEGs) were screened using the GEO2R and Venn diagram tools. Then, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed. Gene set enrichment analysis (GSEA) was performed to analyze the three gene expression profiles. Moreover, a protein-protein interaction (PPI) network of the DEGs was constructed, and functional enrichment analysis was performed. On this basis, hub genes from critical PPI subnetworks were explored with Cytoscape software. The expression of these genes in tumors was verified, and survival analysis of potential prognostic genes from critical subnetworks was conducted. Functional annotation, multiple gene comparison and dimensionality reduction in candidate genes indicated the clinical significance of potential targets.

Results: A total of 476 DEGs were screened: 253 upregulated genes and 223 downregulated genes. DEGs were enriched in 22 biological processes, 16 cellular components and 9 molecular functions in precancerous lesions and cervical cancer. DEGs were mainly enriched in 10 KEGG pathways. Through intersection analysis and data mining, 3 key KEGG pathways and related core genes were revealed by GSEA. Moreover, a PPI network of 476 DEGs was constructed, hub genes from 12 critical subnetworks were explored, and a total of 14 potential molecular targets were obtained.

Conclusions: These findings promote the understanding of the molecular mechanism of and clinically related molecular targets for cervical cancer.

Citing Articles

Correlation analysis on risk factors for cervical cancer in perimenopausal women.

Gong L, Xiao Q, Xie X, Zheng Q Am J Transl Res. 2025; 17(1):211-220.

PMID: 39959217 PMC: 11826191. DOI: 10.62347/KOWP5000.

Tendomodulin in pan-cancer analysis: exploring its impact on immune modulation and uncovering functional insights in colorectal cancer.

Chen J, Hu Q, Zhang C, Zhao A, Guan B, Wang Y BMC Cancer. 2025; 25(1):239.

PMID: 39934677 PMC: 11817044. DOI: 10.1186/s12885-025-13608-z.

PLOD2 exacerbates cervical squamous cell carcinoma by suppressing p53 by binding to YAP1.

Yin M, Weng Y, Qi T Mol Med Rep. 2024; 31(1).

PMID: 39513600 PMC: 11576930. DOI: 10.3892/mmr.2024.13388.

Deciphering Immunotoxicity in Animal-Derived Biomaterials: A Genomic and Bioinformatics Approach.

Lian H, Liu Y, Ke L, Han Q Int J Mol Sci. 2024; 25(20).

PMID: 39456747 PMC: 11507131. DOI: 10.3390/ijms252010963.

Exploring MPC1 as a potential ferroptosis-linked biomarker in the cervical cancer tumor microenvironment: a comprehensive analysis.

Li M, Xu T, Yang R, Wang X, Zhang J, Wu S BMC Cancer. 2024; 24(1):1258.

PMID: 39390460 PMC: 11465577. DOI: 10.1186/s12885-024-12622-x.

References

Bourmenskaya O, Shubina E, Trofimov D, Rebrikov D, Sabdulaeva E, Nepsha O . Host gene expression profiling of cervical smear is eligible for cancer risk evaluation. J Clin Pathol. 2012; 66(4):282-5. DOI: 10.1136/jclinpath-2012-201313. View

Guo W, Yu H, Zhang L, Chen X, Liu Y, Wang Y . Effect of hyperoside on cervical cancer cells and transcriptome analysis of differentially expressed genes. Cancer Cell Int. 2019; 19:235. PMC: 6734331. DOI: 10.1186/s12935-019-0953-4. View

Niu G, Wang D, Pei Y, Sun L . Systematic identification of key genes and pathways in the development of invasive cervical cancer. Gene. 2017; 618:28-41. DOI: 10.1016/j.gene.2017.03.018. View

Gakiopoulou H, Korkolopoulou P, Levidou G, Thymara I, Saetta A, Piperi C . Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications. Br J Cancer. 2007; 97(8):1124-34. PMC: 2360432. DOI: 10.1038/sj.bjc.6603992. View

Zhou Y, Fan W, Deng J, Xi H . Establishment and analysis of the prediction model for cervical squamous cell carcinoma. Eur Rev Med Pharmacol Sci. 2017; 21(22):5042-5048. DOI: 10.26355/eurrev_201711_13816. View

Babion I, Miok V, Jaspers A, Huseinovic A, Steenbergen R, van Wieringen W . Identification of Deregulated Pathways, Key Regulators, and Novel miRNA-mRNA Interactions in HPV-Mediated Transformation. Cancers (Basel). 2020; 12(3). PMC: 7140059. DOI: 10.3390/cancers12030700. View

Liu J, Nie S, Gao M, Jiang Y, Wan Y, Ma X . Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis. J Cell Physiol. 2019; 234(11):21260-21273. DOI: 10.1002/jcp.28731. View

Szklarczyk D, Gable A, Lyon D, Junge A, Wyder S, Huerta-Cepas J . STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018; 47(D1):D607-D613. PMC: 6323986. DOI: 10.1093/nar/gky1131. View

Wen X, Liu S, Cui M . Effect of BRCA1 on the Concurrent Chemoradiotherapy Resistance of Cervical Squamous Cell Carcinoma Based on Transcriptome Sequencing Analysis. Biomed Res Int. 2020; 2020:3598417. PMC: 7333031. DOI: 10.1155/2020/3598417. View

10.

Bader G, Hogue C . An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 2003; 4:2. PMC: 149346. DOI: 10.1186/1471-2105-4-2. View

11.

Leal Jr S, Gulley M . Current and Emerging Molecular Tests for Human Papillomavirus-Related Neoplasia in the Genomic Era. J Mol Diagn. 2017; 19(3):366-377. PMC: 5417044. DOI: 10.1016/j.jmoldx.2017.01.006. View

12.

Klymenko T, Gu Q, Herbert I, Stevenson A, Iliev V, Watkins G . RNA-Seq Analysis of Differentiated Keratinocytes Reveals a Massive Response to Late Events during Human Papillomavirus 16 Infection, Including Loss of Epithelial Barrier Function. J Virol. 2017; 91(24). PMC: 5709591. DOI: 10.1128/JVI.01001-17. View

13.

Papasavvas E, Kossenkov A, Azzoni L, Zetola N, Mackiewicz A, Ross B . Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ women. Carcinogenesis. 2018; 40(2):225-233. PMC: 6487677. DOI: 10.1093/carcin/bgy149. View

14.

van Dam P, Rolfo C, Ruiz R, Pauwels P, Van Berckelaer C, Trinh X . Potential new biomarkers for squamous carcinoma of the uterine cervix. ESMO Open. 2018; 3(4):e000352. PMC: 6045706. DOI: 10.1136/esmoopen-2018-000352. View

15.

Li S, Liu N, Piao J, Meng F, Li Y . CCNB1 Expedites the Progression of Cervical Squamous Cell Carcinoma via the Regulation by FOXM1. Onco Targets Ther. 2020; 13:12383-12395. PMC: 7721124. DOI: 10.2147/OTT.S279951. View

16.

Wang R, Pan W, Jin L, Huang W, Li Y, Wu D . Human papillomavirus vaccine against cervical cancer: Opportunity and challenge. Cancer Lett. 2019; 471:88-102. DOI: 10.1016/j.canlet.2019.11.039. View

17.

Zong S, Liu X, Zhou N, Yue Y . E2F7, EREG, miR-451a and miR-106b-5p are associated with the cervical cancer development. Arch Gynecol Obstet. 2019; 299(4):1089-1098. DOI: 10.1007/s00404-018-5007-y. View

18.

Zhao J, Zhang L, Guo X, Wang J, Zhou W, Liu M . miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells. IUBMB Life. 2015; 67(5):380-94. DOI: 10.1002/iub.1381. View

19.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

20.

Chin C, Chen S, Wu H, Ho C, Ko M, Lin C . cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014; 8 Suppl 4:S11. PMC: 4290687. DOI: 10.1186/1752-0509-8-S4-S11. View